181 related articles for article (PubMed ID: 18369821)
1. Knockdown of telomerase RNA using hammerhead ribozymes and RNA interference.
Li S; Nosrati M; Kashani-Sabet M
Methods Mol Biol; 2007; 405():113-31. PubMed ID: 18369821
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
[TBL] [Abstract][Full Text] [Related]
4. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
[TBL] [Abstract][Full Text] [Related]
5. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
[TBL] [Abstract][Full Text] [Related]
6. Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells.
Wang Y; Duan HG; Chen SM; Xiao BK; Cheng J; Tao ZZ
J Laryngol Otol; 2007 May; 121(5):476-82. PubMed ID: 17156515
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
8. Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells.
de Souza Nascimento P; Alves G; Fiedler W
Oncol Rep; 2006 Aug; 16(2):423-8. PubMed ID: 16820926
[TBL] [Abstract][Full Text] [Related]
9. [Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy].
Yokoyama Y; Takahashi Y; Shinohara A; Tamaya T
Nihon Rinsho; 1998 May; 56(5):1126-30. PubMed ID: 9613108
[TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell lines.
Kraemer K; Fuessel S; Meye A
Methods Mol Biol; 2007; 405():9-22. PubMed ID: 18369813
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity.
Qian X; Cheng J; Chen A; Wang Y; Tao Y; Cao J; Feng Z
Oncol Rep; 2008 Feb; 19(2):575-81. PubMed ID: 18202810
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of telomerase activity in human promyelocytic cell line using RNA interference.
Miri-Moghaddam E; Deezagi A; Soheili ZS
Ann Hematol; 2009 Dec; 88(12):1169-76. PubMed ID: 19415276
[TBL] [Abstract][Full Text] [Related]
13. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T
Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of telomerase activity by plasmid-mediated RNA interference].
Li Y; Li M; Peng Y; Jiang Z; Li W; Li H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):615-9. PubMed ID: 16856401
[TBL] [Abstract][Full Text] [Related]
15. Validation of telomerase and survivin as anticancer therapeutic targets using ribozymes and small-interfering RNAs.
Zaffaroni N; Pennati M; Folini M
Methods Mol Biol; 2007; 361():239-63. PubMed ID: 17172716
[TBL] [Abstract][Full Text] [Related]
16. Expression and suppression of human telomerase RNA.
Li S; Blackburn EH
Cold Spring Harb Symp Quant Biol; 2006; 71():211-5. PubMed ID: 17381299
[TBL] [Abstract][Full Text] [Related]
17. [Study on telomerase inhibition by ribozyme targeted to telomerase RNA component].
Qu Y; OuYang X; Liu S; Peng X; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Jun; 16(3):133-7. PubMed ID: 10359859
[TBL] [Abstract][Full Text] [Related]
18. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
Kondo Y; Kondo S
Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
[TBL] [Abstract][Full Text] [Related]
19. Validation of tissue-specific promoter-driven tumor-targeting trans-splicing ribozyme system as a multifunctional cancer gene therapy device in vivo.
Song MS; Jeong JS; Ban G; Lee JH; Won YS; Cho KS; Kim IH; Lee SW
Cancer Gene Ther; 2009 Feb; 16(2):113-25. PubMed ID: 18758435
[TBL] [Abstract][Full Text] [Related]
20. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
